# FDA 483 - Syed K. Lateef, M.D. - June 02, 2023

Source: https://www.globalkeysolutions.net/records/483/syed-k-lateef-md/92608e2f-f7a5-422a-8fa3-3f9f4479769f

> FDA 483 for Syed K. Lateef, M.D. on June 02, 2023. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Syed K. Lateef, M.D.
- Inspection Date: 2023-06-02
- Product Type: drugs
- Office Name: Office of Medical Device and Radiological Health Division II
- Summary: An FDA inspection of Syed K. Lateef, M.D., a clinical investigator in Kissimmee, FL, revealed significant deficiencies in the conduct of a clinical study. The firm failed to adhere to the investigational plan by not ensuring subjects met all eligibility criteria. Specifically, required screening tests were not performed for four subjects, resulting in three ineligible subjects being dosed with investigational product.

## Related Officers

- [issuing_officer](https://www.globalkeysolutions.net/people/sheri-l-stephenson/dd4f3755-bb3b-4a14-a08f-8d59fbb0b6fa)

Company: https://www.globalkeysolutions.net/companies/syed-k-lateef-md/f4576215-3e8b-49b8-8c29-05dba41d1816

Office: https://www.globalkeysolutions.net/offices/office-of-medical-device-and-radiological-health-division-ii/ae9bd439-479a-420d-9dd8-9fe1fc0863d6